SS 02 - GYN 1: Developmental Therapies and Quality Assurance in Early Phase Gynecologic Clinical Trials

Moderator(s)

• TM

  Teresa Meier, MD

  University of Cincinnati
  Cincinnati, OH
• 

  Scott Silva, MD, PhD

  University of Louisville Radiation Oncology
  Louisville, KY

Presentations:

• 8:00 AM – 8:10 AM ET

  Phase I Clinical Trial of Lobaplatin Combined with Image-Guided Volume-Modulated Arc Radiation Therapy in Locally Advanced Cervical Cancer
  

  Presenter: Jing You, MD
• 8:10 AM – 8:20 AM ET

  Early Assessment of Response Using ctDNA as a Non-Invasive Biomarker in Patients with Gynecologic Malignancies Undergoing Radiotherapy
  

  Presenter: Gabriella Wernicke, MD, MS – Northwell Health Cancer Institute
• 8:20 AM – 8:30 AM ET

  Moderated Hypofractionated Online Adaptive Radiotherapy in Locally Advanced Cervical Cancer: A Prospective 1 Clinical Trial
  

  Presenter: Zheng Zeng, MD – Peking Union Medical College Hospital
• 8:30 AM – 8:40 AM ET

  Acceleration of Overall Treatment Time by Mono-Application Multifractionated Brachytherapy over 48 Hours vs. Sequential Weekly Application Brachytherapy in Carcinoma Cervix - Multi-Institutional, Subc
  

  Presenter: Krithikaa Sekar, MD, MBBS – Healthcare Global Enterprises Ltd.
• 8:40 AM – 8:50 AM ET

  Image Guided Brachytherapy Quality Assurance on NRG GY017, an NRG Oncology Clinical Trial Investigating the Sequencing of Immunotherapy and Chemoradiation for Locally Advanced Cervical Cancer
  

  Presenter: Hayeon Kim, PhD – Magee Womens Hospital of University of Pittsburgh Medical Center and Hillman Cancer Center
• 8:50 AM – 9:00 AM ET

  Discussant
  

  Discussant: Scott Glaser, MD – City of Hope National Medical Center